A038290 Stock Overview
Provides precision medicine and bio-engineering healthcare services in Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Macrogen, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩16,100.00 |
| 52 Week High | ₩26,700.00 |
| 52 Week Low | ₩14,920.00 |
| Beta | -0.15 |
| 11 Month Change | -12.50% |
| 3 Month Change | -16.62% |
| 1 Year Change | -24.59% |
| 33 Year Change | -42.29% |
| 5 Year Change | -30.90% |
| Change since IPO | -27.04% |
Recent News & Updates
Macrogen, Inc.'s (KOSDAQ:038290) Low P/S No Reason For Excitement
Nov 13
Macrogen, Inc.'s (KOSDAQ:038290) Revenues Are Not Doing Enough For Some Investors
Jul 24Recent updates
Macrogen, Inc.'s (KOSDAQ:038290) Low P/S No Reason For Excitement
Nov 13Macrogen, Inc.'s (KOSDAQ:038290) Revenues Are Not Doing Enough For Some Investors
Jul 24Macrogen's (KOSDAQ:038290) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 02Macrogen (KOSDAQ:038290) Has Debt But No Earnings; Should You Worry?
Mar 03Reflecting on Macrogen's (KOSDAQ:038290) Share Price Returns Over The Last Three Years
Jan 09
Shareholder Returns
| A038290 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | 1.4% | -9.0% | -2.8% |
| 1Y | -24.6% | 33.1% | -3.4% |
Return vs Industry: A038290 underperformed the KR Life Sciences industry which returned 33.1% over the past year.
Return vs Market: A038290 underperformed the KR Market which returned -3.4% over the past year.
Price Volatility
| A038290 volatility | |
|---|---|
| A038290 Average Weekly Movement | 4.1% |
| Life Sciences Industry Average Movement | 8.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A038290 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A038290's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 516 | Changhoon Kim | www.macrogen.com |
Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In Situ/spatial) services. The company also provides whole genome, whole exome, transcriptome, epigenome, and metagenome sequencing services; standard sequencing, identification, fragment, customized sequencing, and human ID services; expression, genome, and epigenome microarray; proteomics olink; gene synthesis; DNA and RNA oligo synthesis, and peptide synthesis; and CRISPR knock-in/out, GEM, and mass production services.
Macrogen, Inc. Fundamentals Summary
| A038290 fundamental statistics | |
|---|---|
| Market cap | ₩160.66b |
| Earnings (TTM) | -₩20.48b |
| Revenue (TTM) | ₩131.02b |
1.2x
P/S Ratio-7.8x
P/E RatioIs A038290 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A038290 income statement (TTM) | |
|---|---|
| Revenue | ₩131.02b |
| Cost of Revenue | ₩80.78b |
| Gross Profit | ₩50.24b |
| Other Expenses | ₩70.72b |
| Earnings | -₩20.48b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.05k |
| Gross Margin | 38.35% |
| Net Profit Margin | -15.63% |
| Debt/Equity Ratio | 35.6% |
How did A038290 perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield-15%
Payout RatioDoes A038290 pay a reliable dividends?
See A038290 dividend history and benchmarks| Macrogen dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 25 2025 |
| Days until Ex dividend | 37 days |
| Days until Dividend pay date | 156 days |
Does A038290 pay a reliable dividends?
See A038290 dividend history and benchmarks